Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. PPD, Inc.
  6. Summary
    PPD   US69355F1021

PPD, INC.

(PPD)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/26/2021 07/27/2021 07/28/2021 07/29/2021 07/30/2021 Date
46(c) 45.95(c) 46.06(c) 46.18(c) 46.12(c) Last
1 712 942 1 571 137 1 521 288 1 695 462 979 156 Volume
-0.35% -0.11% +0.24% +0.26% -0.13% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 5 642 M - -
Net income 2021 329 M - -
Net Debt 2021 3 060 M - -
P/E ratio 2021 45,9x
Yield 2021 0,02%
Sales 2022 6 021 M - -
Net income 2022 494 M - -
Net Debt 2022 2 611 M - -
P/E ratio 2022 33,9x
Yield 2022 -
Capitalization 16 203 M 16 203 M -
EV / Sales 2021 3,41x
EV / Sales 2022 3,12x
Nbr of Employees 28 000
Free-Float 61,4%
More Financials
Company
PPD, Inc. provides drug development services to the biopharmaceutical industry. The Company provides clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations, as well as other industry participants. The Company’s business segments include Clinical Development Services segment and Laboratory Services segment. Its Clinical Development Services... 
More about the company
Ratings of PPD, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about PPD, INC.
07/29PPD : Management's Discussion and Analysis of Financial Condition and Results of..
AQ
07/28PPD : Q2 Results Increase from Year Ago
MT
07/28PPD : Reports Second Quarter and Year-To-Date 2021 Results (Form 8-K)
PU
07/28PPD : Earnings Flash (PPD) PPD Posts Q2 Revenue $1.58B
MT
07/28PPD : Earnings Flash (PPD) PPD Posts Q2 EPS $0.39
MT
07/28PPD : Reports Second Quarter and Year-To-Date 2021 Results
BU
07/28PPD, Inc. Announces Unaudited Consolidated Earnings Results for the Second Qu..
CI
07/28PPD, INC. : Results of Operations and Financial Condition, Financial Statements ..
AQ
07/20PPD : Recognized as a Best Place to Work in Asia
BU
07/12PPD : Announces Second Quarter 2021 Earnings Conference Call
BU
06/08ANALYST RECOMMENDATIONS : Amgen, Biogen, Halfords, J Sainsbury, Uber...
06/07CORRECTION : Mizuho Securities Maintains Price Target for PPD at $47.50, Reitera..
MT
06/07PPD : Mizuho Securities Adjusts PPD Price Target to $38 From $47.50, Maintains N..
MT
05/27PPD : Named ‘Most Innovative CRO' by Triangle Business Journal
BU
05/24PPD : Opens Multipurpose Clinical Research Laboratory in Suzhou, China
BU
More news
News in other languages on PPD, INC.
04/16Pump / dump #7
04/16STOCK MARKET PARIS : La croissance chinoise s'invite chez les sorcières
04/16EN DIRECT DES MARCHES  : L'Oréal, FDJ, Fnac Darty, HelloFresh, Daimler, GSK, Sco..
04/15Thermo Fisher übernimmt Auftragsforscher PPD für 21 Mrd Dollar
04/15DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 15.04.2021 - 15.15 Uhr
More news
Analyst Recommendations on PPD, INC.
More recommendations
Chart PPD, INC.
Duration : Period :
PPD, Inc. Technical Analysis Chart | PPD | US69355F1021 | MarketScreener
Technical analysis trends PPD, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Last Close Price 46,12 $
Average target price 47,55 $
Spread / Average Target 3,09%
EPS Revisions
Managers and Directors
David S. Simmons Chairman & Chief Executive Officer
Christopher G. Scully CFO, Treasurer, Executive VP & Assistant Secretary
David Johnston Executive VP-Global Clinical Development
Karen Kaucic Chief Medical Officer & Executive Vice President
Rob Petrie Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
PPD, INC.34.78%16 203
MODERNA, INC.238.47%141 980
LONZA GROUP AG23.98%57 809
IQVIA HOLDINGS INC.38.25%47 462
CELLTRION, INC.-29.39%30 059
SEAGEN INC.-12.42%27 837